- NervGen Pharma (OTCQX:NGENF) has announced the appointment of Mr. Michael Kelly to the position of President & CEO effective April 10, 2023.
- Mr. Kelly has also been appointed as a member of NervGen's Board of Directors.
- Mr. Kelly currently serves on the Board of Directors of ARS Pharmaceuticals, which he joined in May 2019.